ÎÚÑ»´«Ã½

The U.S. already pays more than other countries do for brand-name drugs. Tariffs could raise prices more.

Digital violence, such as blackmail, stalking, and the non-consensual sharing of intimate images, is rising—and becoming normalized in some low- and middle-income countries, per a new report focused on Kenya, Ghana, Colombia, and Vietnam. 

The Rakai Health Sciences Program transformed global AIDS policies and cut new cases by 90%. How will its storied research and clinical legacy continue?

Bringing people together on causes that matter is a charge for every one of us.

Cuts to U.S. aid funding will have ramifications abroad—and at home.

An expert in global aid and human rights explains some of the ways disengaging from global health partnerships may impact the U.S.

Clinical trials, government agencies, and data systems ensure vaccines meet high safety standards.

The ongoing outbreak poses a low risk to the public, but it signals cracks in our public health infrastructure.

Leaving the World Health Organization would have broad impacts.

Last week the Louisiana Department of Health announced the first U.S. death from H5N1. Samples taken from the individual suggest that the virus has begun to adapt to infect humans better. 

The U.S. government’s approach to public health seems certain to change when the second Trump administration begins on January 20. But what powers do states have to determine and take action on their own public health priorities?

The latest on the virus’s spread, potential economic impacts, vaccine development, and how concerned the general public should be.

Experts share how they expect a Harris or Trump administration would affect abortion access, health care costs, federal agencies, global health, gun violence, and immigration.

The 2024 U.S. elections will shape the future of global health policy, determining whether the nation will continue to provide crucial leadership to advance global health. 

A global agreement on pandemic preparedness and response would address the weaknesses exposed by COVID-19, but countries are still struggling to find consensus.